References
- Hellerstedt BA, Pienta KJ. The current state of hormonal therapy for prostate cancer. CA Cancer J Clin. 2002 : 52, 154-79. https://doi.org/10.3322/canjclin.52.3.154
- Luciana D. Apoptosis induction in DU-145 human prostate carcinoma cells. Tissue and Cell. 2005 : 37, 379-84. https://doi.org/10.1016/j.tice.2005.06.006
- Timme TL, Satoh T, Tahir SA, Wang H, The BS, Butler EB, Miles BJ, Amato RJ, Kadmon D, Thompson TC. Therapeutic targets for metastatic prostate cancer. Curr Drug Targets. 4. 2003 : 251-61. https://doi.org/10.2174/1389450033491127
- Santos AF, Huang H, Tindall DJ. The androgen receptor: a potential target for therapy of prostate cancer. Steroids. 2004 : 69, 79-85. https://doi.org/10.1016/j.steroids.2003.10.005
- Srilatha S, Aruna VK, Donna MP, David F. Genistein potentiates the growth inhibitory effects of 1, 25-dihydroxyvitamin D3 in DU145 human prostate cancer cells: Role of the direct inhibition of CYP24 enzyme activity. Molecular and Cellular Endocrinology 241. 2005 : 49-61. https://doi.org/10.1016/j.mce.2005.05.001
- Brown RL, Haley TL, West KA, Crabb JW. Pseudechetoxin: a peptide blocker of cyclic nucleotide-gated ion channels. Proc Natl Acad Sci USA. 1999 ; 96 : 7549.
- Sher E, Giovannini F, Boot J, Lang B. Peptide neurotoxins, small-celllung carcinoma andneurological paraneoplastic syndromes. Biochimie. 2000 ; 82 : 92736.
- Van Lunteren E, Moyer M. Peptide toxin blockers of voltage-sensitive K+ channels: Inotropic effects on diaphragm. J Appl Physiol. 1999 ; 3 : 100916.
- Park HJ, Lee SH, Son DJ, Oh KW, Kim KH, Song HS, Kim GJ, Oh GT, Yoon DY and Hong JT. Antiarthritic effect of BV: inhibition of inflammation mediator generation by suppression of NF-kappaB through interaction with the p50 subunit. Arthritis Rheum. 2004 ; 50 : 3504-15. https://doi.org/10.1002/art.20626
- Holle L, Song W, Holle E, Wei Y, Wagner T, Yu X. A matrix metalloproteinase 2 cleavable melittin/avidin conjugate specifically targets tumor cells in vitro and in vivo. Int J Oncol. 2003 : 22, 93-8.
- Park HJ, Lee YK, Song HS, Kim KJ, Son DJ, Lee JW and Hong JT. Melittin inhibits human prostate cancer cell growth through induction of apoptotic cell death. J Toxicol Pub Health. 2006 ; 22(1) : 31-7.
-
HS Lee, HS Song. BV inhibits LNCaP cell proliferation through induction of apoptosis via inactivation of NF-
$\kappa$ B. Journal of Acupuncture and Moxibustion. 2007 ; 25(2) : 59-74. -
HJ Oh, HS Song. BV inhibits PC-3 cell proliferation through induction of apoptosis via inactivation of NF-
$\kappa$ B. Journal of Acupuncture and Moxibustion. 2010 ; 27(3) : 1-14. - DJ Son, MH Park, SJ Chae et al. Inhibitory effect of snake venom toxin from Vipera lebetina turanica on hormone-refractory human prostate cancer cell growth: induction of apoptosis through inactivation of nuclear factor KB. Mol Cancer Ther. 2007 ; 6(2) : 675-83. https://doi.org/10.1158/1535-7163.MCT-06-0328
- Lowe SW, Lin AW. Apoptosis in cancer. Carcinogenesis. 2000 ; 21 : 48595.
- Guseva NV, Taghiyev AF, Rokhlin OW, Cohen MB. Death receptor-induced cell death in prostate cancer. J Cell Biochem. 2004 ; 91 : 7099.
- Gurumurthy S, Vasudevan KM, Rangnekar VM. Regulation of apoptosis in prostate cancer. Cancer Metastasis Rev. 2001 ; 20 : 22543.
- Kantoff PW. New agents in the therapy of hormone-refractory patients with prostate cancer. Semin Oncol. 1995 ; 22(1) : 324.
- Suh J, Payvandi F, Edelstein LC et al. Mechanisms of constitutive NF-kappaB activation in human prostate cancer cells. Prostate. 2002 ; 52 : 183200.
-
Raj GV, Sekula JA, Guo R, Madden JF, Daaka Y. Lysophosphatidic acid promotes survival of androgen-insensitive prostate cancer PC3 cells via activation of NF-
$\kappa$ B. Prostate. 2004 ; 61 : 10513. - Anton S, Andrew VS, Jozsef LV, Marta Z, Ren-Zhi C, Benjamin B, Brian D. Hammann, Patricia Armatis, Celia A. Kanashiro.Inhibition of human androgen-independent PC-3 and DU-145 prostate cancers by antagonists of bombesin and growth hormone releasing hormone is linked to PKC, MAPK and c-jun intracellular signalling. European Journal of Cancer 41. 2005 : 2735-44. https://doi.org/10.1016/j.ejca.2005.08.022
- Kushlani G, Darrell KM, Richard ES, DDS AW. Inhibition of nuclear factor B induces apoptosis following treatment with tumor necrosis factor and an antioxidant in human prostate cancer cells. Cancer Detection and Prevention 26. 2002 : 229-37. https://doi.org/10.1016/S0361-090X(02)00061-2